Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Olsson

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
Haemostasis|January 1, 1979
Serotonin uptake and release by platelets adhering to polyethyleneR Malmgren, R Larsson, P Olsson, et al.
Progress in Clinical and Biological Research|January 1, 1987
Endotoxin inactivation in plasma from patients with gram-negative infection--an in vitro studyP Olofsson, C Olofsson, G Nylander, et al.
Lakartidningen|September 22, 1993
[Mammography screening. A pilot study of the psychological effects]P Olsson, K Armelius, P Lenner, et al.
Lancet (London, England)|December 1, 1979
Migraine, a platelet disorderR Malmgren, P Olsson, G Tornling, et al.
Journal of Biomedical Materials Research|May 1, 1995
Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequenceJ Sanchez, G Elgue, J Riesenfeld, et al.
Thrombosis Research|June 1, 1980
The 5-hydroxytryptamine take-up mechanism in normal platelets and platelets from migraine and asthmatic patientsR Malmgren, P Olsson, G Tornling, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1981
Polarographic pO2 sensors with heparinized membranes for in vitro and continuous in vivo registrationE Nilsson, G Edwall, R Larsson, et al.
Journal of Biomedical Materials Research|October 23, 1997
Inhibition of the plasma contact activation system of immobilized heparin: relation to surface density of functional antithrombin binding sitesJ Sánchez, G Elgue, J Riesenfeld, et al.
Thrombosis Research|September 1, 1994
Coagulation inhibition capacities of low-molecular mass and unfractionated heparin, as determined by thrombin generationG Elgue, J Sanchez, N Egberg, et al.
Thrombosis Research|June 1, 1991
Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wallB Pasche, J Swedenborg, S Frebelius, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
Haemostasis|January 1, 1979
Serotonin uptake and release by platelets adhering to polyethyleneR Malmgren, R Larsson, P Olsson, et al.
Progress in Clinical and Biological Research|January 1, 1987
Endotoxin inactivation in plasma from patients with gram-negative infection--an in vitro studyP Olofsson, C Olofsson, G Nylander, et al.
Lakartidningen|September 22, 1993
[Mammography screening. A pilot study of the psychological effects]P Olsson, K Armelius, P Lenner, et al.
Lancet (London, England)|December 1, 1979
Migraine, a platelet disorderR Malmgren, P Olsson, G Tornling, et al.
Journal of Biomedical Materials Research|May 1, 1995
Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequenceJ Sanchez, G Elgue, J Riesenfeld, et al.
Thrombosis Research|June 1, 1980
The 5-hydroxytryptamine take-up mechanism in normal platelets and platelets from migraine and asthmatic patientsR Malmgren, P Olsson, G Tornling, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1981
Polarographic pO2 sensors with heparinized membranes for in vitro and continuous in vivo registrationE Nilsson, G Edwall, R Larsson, et al.
Journal of Biomedical Materials Research|October 23, 1997
Inhibition of the plasma contact activation system of immobilized heparin: relation to surface density of functional antithrombin binding sitesJ Sánchez, G Elgue, J Riesenfeld, et al.
Thrombosis Research|September 1, 1994
Coagulation inhibition capacities of low-molecular mass and unfractionated heparin, as determined by thrombin generationG Elgue, J Sanchez, N Egberg, et al.
Thrombosis Research|June 1, 1991
Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wallB Pasche, J Swedenborg, S Frebelius, et al.
Pageof 22